Global CRISPR Technology Market Research Report 2021: Focus on Design Tools, Plasmids and Vectors, Cas9 and G-RNA, and Delivery System Products – ResearchAndMarkets.com

0


DUBLIN – (COMMERCIAL THREAD)–The “Global CRISPR Technology Market Report 2021: Growth and Change of COVID-19 to 2030” the report was added to ResearchAndMarkets.com offer.

The global CRISPR technology market is expected to grow from $ 0.8 billion in 2020 to $ 0.95 billion in 2021 at a compound annual growth rate (CAGR) of 18.8%. The market is expected to reach $ 2.22 billion in 2025 at a CAGR of 24%.

The CRISPR technology market includes sales of CRISPR technology products and services, which is gene editing technology that enables researchers to modify DNA sequences and alter gene function. Market generated revenue includes sales of products such as design tools, plasmids and vectors, Cas9 and gRNA, libraries and delivery system products and services which include vector design and construction, screening and cell line engineering.

These products and services are used in genome editing / genetic engineering, genetically modified organisms, agricultural biotechnology and others which include gRNA database / gene library, CRISPR plasmid, gene engineering. human stem cells and cell lines by end users. End users include pharmaceutical and biopharmaceutical companies, biotechnology companies, academic and research institutes, and contract research organizations.

The CRISPR Technology market covered in this report is segmented by Product Type into Design Tools, Plasmid and Vector, CAS9 and G-RNA, Delivery System Products. It is also segmented by application into Genome Editing / Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology, Others and by End User into Industrial Biotechnology, Biological Research, Agricultural Research, Therapeutics and Drug Discovery.

Strict government regulations are expected to retard the growth of the CRISPR technology market during the period. There is no internationally agreed regulatory framework for gene editing products and countries are assessing whether and to what extent current regulations are adequate for research conducted with gene editing and applications and products related to gene editing.

The Court of Justice of the European Union has ruled that it will treat genetically modified crops as genetically modified organisms, subject to strict regulation. In April 2019, the Australian government said that the Office of the Gene Technology Regulator (OGTR) would only regulate gene-editing technologies that use a pattern or insert other genetic material into the cell.

According to a 2020 article, in India, in accordance with national guidelines for stem cell research, genome modification including gene editing by CRISPR-Cas9 technology from stem cells, germ stem cells or gametes and human embryos is limited only to in-vitro studies. Thus, strict government regulations pose a threat to the growth of the market.

The application of CRISPR technology as a diagnostic tool is expected to drive the market during the period. The Sherlock CRISPR SARS-CoV-2 Kit is the first diagnostic kit based on CRISPR technology for infectious diseases due to COVID-19.

In May 2020, the FDA announced emergency use authorization for Sherlock BioSciences Inc’s Sherlock CRISPR SARS-CoV-2 Kit, which is a CRISPR-based Specific High-sensitivity Enzymatic Reporter (SHERLOCK) diagnostic test. . This test helps to specifically target SARS-CoV-2 virus RNA or DNA sequences from specimens or samples such as nasal swabs from the upper respiratory tract and fluid in the lungs from ‘bronchoalveolar lavage samples.

This diagnostic kit has high specificity and sensitivity and does not provide false negative or positive results. Expanding the application of CRISPR technology for the diagnosis of infectious diseases will increase the demand for CRISPR technology products and services.

Several advancements in CRISPR technology are in vogue in the market during the period. Technological advances will help reduce errors, limit unwanted effects, improve the precision of the tool, broaden its applications, develop gene therapies, etc.

In 2019, a study published in Springer Nature announced the development of an advanced new ultra-precise CRISPR tool that allows researchers to better control DNA changes. This tool appears to have the ability to deliver a wider variety of genetic modifications that could potentially open up conditions that have challenged gene editors.

Additionally, in 2020, another study from Springer Nature said that researchers used enzyme engineering to increase the technical precision of the error-prone CRISPR-Cas9 system to precisely target DNA without introducing so many mutations. unwanted. Advances in CRISPR technology will translate into better tools capable of delivering better results.

The main players in the CRISPR technology market are

  • Thermo Fisher Scientific

  • GenScript biotechnology company

  • CRISPR Therapeutics AG

  • Editas Medicine

  • Horizon Discovery Plc.

  • Integrated DNA Technologies Inc. (Danaher)

  • Origene Technologies Inc.

  • Transposagenbio Biophramaceuticals (Hera Biolabs)

  • Intellia Therapeutics Inc.

  • GeneCopoeia Inc.

  • Merck KGaA

  • Lonza Group Ltd.

  • New England Biolabs Inc.

  • Therapeutic Sangamo

  • Stem cell applied

  • Novartis International SA

  • Égenèse inc.

  • GE Health Dharmacon Inc.

  • Agilent Technologies

  • Caribou biosciences

  • Addgene

  • Synthego Corporation

  • Precision biosciences

  • Cellecta Inc

Main topics covered:

1. Summary

2. Characteristics of the CRISPR technology market

3. CRISPR Technology Market Trends and Strategies

4. Impact of COVID-19 on CRISPR technology

5. Size and Growth of CRISPR Technology Market

5.1. Historical Global CRISPR Technology Market, 2015-2020, in USD Billion

5.1.1. Market pilots

5.1.2. Market restrictions

5.2. Global CRISPR Technology Forecast Market, 2020-2025F, 2030F, in USD Billion

5.2.1. Market pilots

5.2.2. Market restrictions

6. CRISPR technology market segmentation

6.1. Global CRISPR Technology Market, Segmentation by Product Type, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Design tools

  • Plasmid and vector

  • Cas9 and G-ARN

  • Delivery system products

6.2. Global CRISPR Technology Market, Segmentation by Application, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Genome editing / Genetic engineering

  • Genetically modified organism

  • Agricultural biotechnology

  • Others

6.3. Global CRISPR Technology Market, Segmentation by End User, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

  • Industrial biotechnology

  • Biological research

  • Agricultural research

  • Therapeutics and drug discovery

7. Regional and National Analysis of CRISPR Technology Market

7.1. Global CRISPR Technology Market Divided by Region, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

7.2. Global CRISPR Technology Market, Divided by Country, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion

For more information on this report, visit https://www.researchandmarkets.com/r/gvqw3u


Share.

Comments are closed.